JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4601
ADMA Biologics
ADMA
$2.21B
| $59K | ﹤0.01% |
20,251
-2,385
| -11% | -$6.85K |
2018 Q1
9 quarters
|
|
4602
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.32B
| $59K | ﹤0.01% |
950
-681
| -42% | -$39K |
2013 Q2
28 quarters
|
|
4603
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.08B
| $59K | ﹤0.01% |
1,200
| – | – |
2015 Q4
18 quarters
|
|
4604
iShares US Telecommunications ETF
IYZ
$1.1B
| $59K | ﹤0.01% |
2,146
-400,333
| -99% | -$10.9M |
2015 Q4
18 quarters
|
|
4605
Energy Fuels
UUUU
$2.82B
| $59K | ﹤0.01% |
39,229
+9,137
| +30% | +$14.5K |
2018 Q2
8 quarters
|
|
4606
Lakeland Industries
LAKE
$106M
| $58K | ﹤0.01% |
+2,574
| New | +$42.1K |
2020 Q2
0 quarters
|
|
4607
iShares MSCI Global Gold Miners ETF
RING
$2.29B
| $58K | ﹤0.01% |
1,922
| – | – |
2020 Q1
1 quarter
|
|
4608
Safe Bulkers
SB
$996M
| $58K | ﹤0.01% |
47,466
-39,687
| -46% | -$43.5K |
2017 Q4
10 quarters
|
|
4609
Ultralife
ULBI
$108M
| $58K | ﹤0.01% |
+8,343
| New | +$61K |
2020 Q2
0 quarters
|
|
|
ATXI
4610
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $58K | ﹤0.01% |
+5
| New | +$56.4K |
2020 Q2
0 quarters
|
|
|
CURO
4611
DELISTED
CURO Group Holdings Corp.
CURO
| $58K | ﹤0.01% |
7,199
+1,188
| +20% | +$8.45K |
2018 Q1
9 quarters
|
|
|
AC
4612
DELISTED
Associated Capital Group
AC
| $57K | ﹤0.01% |
1,562
+626
| +67% | +$22.4K |
2015 Q4
18 quarters
|
|
4613
Concrete Pumping Holdings
BBCP
$497M
| $57K | ﹤0.01% |
16,561
+8,011
| +94% | +$24.4K |
2019 Q1
5 quarters
|
|
4614
IDEAYA Biosciences
IDYA
$3.6B
| $57K | ﹤0.01% |
+4,045
| New | +$31.9K |
2020 Q2
0 quarters
|
|
4615
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.16B
| $57K | ﹤0.01% |
1,460
-45,026
| -97% | -$1.72M |
2017 Q4
10 quarters
|
|
4616
TELA Bio
TELA
$51M
| $57K | ﹤0.01% |
+4,404
| New | +$57.8K |
2020 Q2
0 quarters
|
|
|
TAST
4617
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $57K | ﹤0.01% |
11,876
+721
| +6% | +$2.72K |
2017 Q4
10 quarters
|
|
|
PTRS
4618
DELISTED
Partners Bancorp Common Stock
PTRS
| $57K | ﹤0.01% |
+8,575
| New | +$59.8K |
2020 Q2
0 quarters
|
|
4619
Dyadic International
DYAI
$17.7M
| $56K | ﹤0.01% |
+6,486
| New | +$43.1K |
2020 Q2
0 quarters
|
|
4620
International Money Express
IMXI
$356M
| $56K | ﹤0.01% |
4,497
-1,309
| -23% | -$13.3K |
2019 Q1
5 quarters
|
|
4621
Milestone Scientific
MLSS
$34.9M
| $56K | ﹤0.01% |
+28,946
| New | +$53K |
2020 Q2
0 quarters
|
|
|
XOMA
4622
DELISTED
Xoma
XOMA
| $56K | ﹤0.01% |
2,857
-14,335
| -83% | -$315K |
2019 Q3
3 quarters
|
|
4623
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.47B
| $55K | ﹤0.01% |
2,179
+700
| +47% | +$17.4K |
2013 Q2
28 quarters
|
|
4624
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$380M
| $55K | ﹤0.01% |
1,202
-57
| -5% | -$2.5K |
2015 Q1
21 quarters
|
|
4625
Schwab US Large- Cap ETF
SCHX
$74.6B
| $55K | ﹤0.01% |
4,452
-978
| -18% | -$11.4K |
2018 Q3
7 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.